AMG National Trust Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.65M Sell
22,461
-5,516
-20% -$1.19M 0.12% 109
2026
Q1
$6.08M Buy
27,977
+4,710
+20% +$1.04M 0.13% 106
2025
Q4
$5.32M Buy
23,267
+164
+0.7% +$37.4K 0.13% 99
2025
Q3
$5.35M Sell
23,103
-91
-0.4% -$18.5K 0.13% 98
2025
Q2
$4.31M Buy
23,194
+418
+2% +$77.7K 0.11% 116
2025
Q1
$4.77M Buy
22,776
+711
+3% +$138K 0.13% 99
2024
Q4
$3.91M Buy
22,065
+16
+0.1% +$2.94K 0.11% 116
2024
Q3
$4.35M Sell
22,049
-5,142
-19% -$960K 0.12% 114
2024
Q2
$4.66M Buy
27,191
+5,685
+26% +$942K 0.13% 113
2024
Q1
$3.92M Sell
21,506
-342
-2% -$58.9K 0.11% 115
2023
Q4
$3.39M Sell
21,848
-418
-2% -$60.9K 0.11% 130
2023
Q3
$3.32M Sell
22,266
-1,400
-6% -$206K 0.12% 116
2023
Q2
$3.19M Sell
23,666
-1,803
-7% -$264K 0.11% 127
2023
Q1
$4.06M Buy
25,469
+4,325
+20% +$661K 0.14% 101
2022
Q4
$3.42M Sell
21,144
-4,726
-18% -$725K 0.12% 113
2022
Q3
$3.47M Buy
25,870
+7,419
+40% +$1.06M 0.13% 116
2022
Q2
$2.72M Sell
18,451
-184
-1% -$28.1K 0.1% 131
2022
Q1
$3.02M Sell
18,635
-41
-0.2% -$5.96K 0.1% 132
2021
Q4
$2.53M Sell
18,676
-385
-2% -$45.5K 0.08% 160
2021
Q3
$2.06M Buy
19,061
+510
+3% +$58.3K 0.07% 178
2021
Q2
$2.09M Sell
18,551
-2,458
-12% -$277K 0.07% 175
2021
Q1
$2.27M Sell
21,009
-22,767
-52% -$2.44M 0.08% 159
2020
Q4
$4.69M Sell
43,776
-21,470
-33% -$2.06M 0.17% 83
2020
Q3
$5.71M Sell
65,246
-21,305
-25% -$2.01M 0.24% 65
2020
Q2
$8.5M Buy
86,551
+11,449
+15% +$1.01M 0.38% 45
2020
Q1
$5.72M Sell
75,102
-2,008
-3% -$171K 0.43% 33
2019
Q4
$6.83M Sell
77,110
-2,646
-3% -$220K 0.39% 32
2019
Q3
$6.04M Sell
79,756
-3,267
-4% -$224K 0.35% 38
2019
Q2
$6.04M Buy
83,023
+452
+0.5% +$35.5K 0.36% 35
2019
Q1
$6.65M Sell
82,571
-3,231
-4% -$264K 0.41% 33
2018
Q4
$7.91M Buy
85,802
+1,191
+1% +$105K 0.55% 30
2018
Q3
$8M Buy
84,611
+1,350
+2% +$128K 0.47% 32
2018
Q2
$7.71M Buy
83,261
+1,068
+1% +$104K 0.48% 31
2018
Q1
$7.78M Sell
82,193
-393
-0.5% -$43.2K 0.5% 34
2017
Q4
$7.99M Buy
82,586
+4,532
+6% +$427K 0.52% 33
2017
Q3
$6.94M Buy
78,054
+761
+1% +$57.9K 0.48% 33
2017
Q2
$5.61M Buy
77,293
+1,106
+1% +$74.4K 0.41% 37
2017
Q1
$4.96M Buy
76,187
+6,654
+10% +$418K 0.38% 39
2016
Q4
$4.35M Buy
69,533
+13,846
+25% +$845K 0.36% 47
2016
Q3
$3.51M Buy
55,687
+3,922
+8% +$254K 0.3% 58
2016
Q2
$3.21M Sell
51,765
-133
-0.3% -$8.1K 0.29% 54
2016
Q1
$2.96M Buy
51,898
+4,297
+9% +$240K 0.27% 58
2015
Q4
$2.82M Buy
47,601
+41,709
+708% +$2.4M 0.26% 58
2015
Q3
$321K Sell
5,892
-25
-0.4% -$1.63K 0.03% 219
2015
Q2
$398K Sell
5,917
-936
-14% -$61.1K 0.04% 199
2015
Q1
$401K Sell
6,853
-2,134
-24% -$129K 0.04% 199
2014
Q4
$588K Buy
8,987
+33
+0.4% +$2.08K 0.06% 162
2014
Q3
$517K Sell
8,954
-27
-0.3% -$1.5K 0.05% 171
2014
Q2
$507K Buy
8,981
+438
+5% +$23K 0.05% 181
2014
Q1
$439K Buy
8,543
+274
+3% +$13.8K 0.05% 191
2013
Q4
$437K Hold
8,269
0.05% 189
2013
Q3
$370K Buy
+8,269
New +$367K 0.05% 184

Other funds holding ABBV

AMG National Trust Bank's ABBV Position: Q2 2026 in Review

AMG National Trust Bank reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $1.19M and leaving 22,461 shares worth $5.65M. The position accounts for 0.12% of the portfolio, ranked #109.

AMG National Trust Bank first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. The position peaked at $8.5M in Q2 2020. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AMG National Trust Bank held 22,461 shares of AbbVie worth $5.65M as of Q2 2026.
  • AMG National Trust Bank sold 5,516 AbbVie shares in Q2 2026, an estimated $1.19M.
  • AbbVie made up 0.12% of AMG National Trust Bank's portfolio in Q2 2026, its #109 holding.
  • AMG National Trust Bank first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
  • AMG National Trust Bank's AbbVie position peaked at $8.5M in Q2 2020.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.